All Professionals
Overview
Amandine Guignard is an associate in the Corporate practice of Paul Hastings and is based in the firm’s Paris office.
Her practice focuses on Mergers & Acquisitions and more particularly on Private Equity transactions.
Education
- HEC Paris, Parcours Grande Ecole, Master in Management et en Droit des Affaires (2020)
- Université Paris I – Panthéon Sorbonne, Master 2, Droit des Affaires et Fiscalité (2020)
Representations
- Advising Société Générale Capital Partenaires, Arkéa Capital and BNP Paribas Développement in connection with the LBO of ACB group.
- Advising Keensight Capital in connection with the LBOs of the Adista and Valiantys groups, the LBU of Unyc, the merger of Sogelink and Geodesial and the sale of Linkbynet to Accenture.
- Advising Andera Partners in connection with the LBO of Senstronic group.
- Advising Ardian Expansion in connection with the OBO of Alixio group.
- Advising Sagard in connection with the OBO of Asobo Studio and in the LBO of the I-Tracing group.
- Advising EQT Private Equity on the acquisition of Cerba Healthcare.
- Advising B & Capital in connection with the LBO of the Be-Cloud group.
- Advising UTAC in connection with the merger with Millbrook.
- Advising Qualium Investissement in connection with the sale of its majority stake in the Labelium group to Charterhouse.
news
- Paul Hastings Advised Andera Partners in Investment in Horus Finance's Fine Art Logistics Division - November 14th, 2024
- Paul Hastings Advised Valiantys, Backed by Keensight Capital, in the LBU of Contegix - October 31st, 2024
- Paul Hastings Advised MML Capital, Bpifrance and the Other Sellers on the Sale of Gravotech to Brady Corporation - September 2nd, 2024
- Paul Hastings Advised Qualium Investissement in Sale of Kermel - April 16th, 2024
- Paul Hastings Advised Menix in Sale of SERF SAS to Stryker - April 3rd, 2024
- Paul Hastings Advised Exens Group In the Acquisition of Bowen - March 28th, 2024
- Paul Hastings Advised Keensight Capital in the Combination of Biovian and 3P Biopharmaceuticals to Create 3PBIOVIAN - February 5th, 2024
- Paul Hastings Advised Crédit Mutuel Equity on Investment in the Claire Group - September 20th, 2023
- Paul Hastings Advised Alixio in the Acquisition of X-PM - June 22nd, 2023
- Paul Hastings Advised Exens Solutions in the Acquisition of AR Electronique - June 14th, 2023
- Paul Hastings Advises EMZ Partners in the OBO on Advancy - March 17th, 2023
- Paul Hastings Advised Valiantys in Several Growth Transactions - January 17th, 2023
- Paul Hastings Advises Andera Partners on Investment in Senstronic - October 14th, 2022
- Arkéa Capital, BNP Paribas Développement and Société Générale Capital Partenaires Acquire ACB - September 29th, 2022
- Keensight Capital Acquires Valiantys - June 29th, 2022
- Eurazeo Invests in WiiSmile - June 16th, 2022
- Ardian Acquires a Stake in Alixio - June 2nd, 2022
Involvement
- Member, Paris Bar (2021)